Contrast agents are chemical substances introduced to the anatomical or functional region being imaged, to increase the differences between different tissues or between normal and abnormal tissue, by altering the relaxation times. MRI contrast agents are classified by the different changes in relaxation times after their injection.
The design objectives for the next generation of MR contrast agents will likely focus on prolonging intravascular retention, improving tissue targeting, and accessing new contrast mechanisms. Macromolecular paramagnetic contrast agents are being tested worldwide. Preclinical data shows that these agents demonstrate great promise for improving the quality of MR angiography, and in quantificating capillary permeability and myocardial perfusion.
Ultrasmall superparamagnetic iron oxide (USPIO) particles have been evaluated in multicenter clinical trials for lymph node MR imaging and MR angiography, with the clinical impact under discussion. In addition, a wide variety of vector and carrier molecules, including antibodies, peptides, proteins, polysaccharides, liposomes, and cells have been developed to deliver magnetic labels to specific sites. Technical advances in MR imaging will further increase the efficacy and necessity of tissue-specific MRI contrast agents.

See also Adverse Reaction and Nephrogenic Systemic Fibrosis.

See also the related poll result: 'The development of contrast agents in MRI is'

(ESR) Electron spin resonance is a spectroscopic technique to identify paramagnetic substances. This magnetic resonance phenomenon investigates the nature of the bonding within molecules by identifying unpaired electrons, e.g. in free radicals and their interaction with their immediate surroundings. The Larmor frequency are much higher than corresponding NMR frequencies in the same static magnetic field.
Nuclei with an odd number of neutrons and/or protons, because of their spin, react like tiny magnets and can be lined up in an applied magnetic field. Energy applied by alternating radio frequency radiation is absorbed when its frequency coincides with that of precession of the electron magnets. The spectrum of radiation absorbed as the field changes gives information valuable in chemistry, biology, and medicine since over 50 years.

(MR) Resonance phenomenon resulting in the absorption and/or emission of electromagnetic energy by nuclei (for that reason also nuclear magnetic resonance) or electrons in a static magnetic field, after excitation by a suitable RF magnetic field.
The peak resonance frequency is proportional to the magnetic field, and is given by the Larmor equation. Only unpaired electrons or nuclei with a spin exhibit magnetic resonance. The absorption or emission of energy by atomic nuclei in an external magnetic field after the application of RF excitation pulses using frequencies, which satisfy the conditions of the Larmor equation.
The magnetic resonance phenomenon may be used in one of these ways:
By manipulation of the external field (application of gradient fields), the resonance frequency can become dependent on spatial location, and hence images may be generated (MRI).
The effect of the electron cloud in any atom or molecule is to slightly shield the nucleus from the external field, thus giving any chemical species a characteristic frequency. This gives rise to 'spectra' where nuclei in a molecule give rise to specific signals, thus facilitating the detection of individual chemicals by means of their frequency spectra (MRS)

Nitroxide radicals (or nitroxyl spin labels) are stable organic compounds with theoretical potential for use as a paramagnetic MRI contrast agent. Similar to gadolinium they have an unpaired electron, a property that provides enhancement in T1 based MRI, and a comparable pharmacokinetic. Depending on their structure and chemical bonding, different nitroxides formula may have the potential for use as cardiovascular imaging agents, to enhance the MR imaging on joints (e.g., dendrimer-linked nitroxides have a strong affinity for cartilage), to evaluate brain tumors and infarction, and as a contrast enhancement agent of body/abdominal NMR imaging. Nitroxides are rapidly enzymatically reduced in tissues to products that do not enhance the NMR signal, which can be a problem for MR imaging. In animal experiments with EPRI (electron paramagnetic resonance imaging), tissue redox studies show differences between tumors and normal tissues, which reflect their respective redox status consistent with the reduction/clearance of nitroxides.

Substances exhibiting paramagnetic properties are used as contrast agents in MR imaging. They have a small but positive magnetic susceptibility (magnetizability - tends to align along the magnetic field). Typical paramagnetic substances usually possess an unpaired electron and include atoms or ions of transition elements, rare earth elements, some metals, and some molecules including molecular oxygen and free radicals.

See also Paramagnetism.